Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Parrot David
Chief Financial Officer at Scribe Therapeutics. Filing since 23 Jul 2026.
CIK 0002127908
Company
Date
Role
Action
Shares
Amount
Of holding
SCTX
Scribe Therapeutics, Inc.
23 Jul 2026
Chief Financial Officer
Bought
2,666
$39.99K
opened
1 decision on file.